Future Studies




This study is investigating whether low-dose aspirin (75mg) reduces the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)Until we complete the research, we will not know whether taking aspirin benefits people with CKD, but we believe that the results of this trial will be extremely important for the NHS.If the benefits of aspirin are shown to outweigh the risks, then treatment will be available immediately to about 3 million people with CKD.


Further Information